Method for treating ocular cancer
US9078895B2 · kind B2 · utility
0Cited by
4References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 5, 2013 |
| Grant date | Jul 14, 2015 |
| Priority date | — |
| Expiry date | Dec 5, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
It has now been found that the p53 pathway is inactivated in ocular cancers such as retinoblastoma. As such, the present invention is a method for inducing ocular cancer cell death using a p53 activator. In particular embodiments, the p53 activator blocks the interaction between DM2 or DMX and p53. As the p53 activator induces ocular cancer cell death, a method for preventing or treating ocular cancer is also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.